WHO on Friday issued formal guidelines recommending against the use of remdesivir for COVID-19 patients, based on a  lack of evidence that the antiviral drug, developed by Gilead, significantly improves patient outcomes. The recommendation followed publication of trial results on the drug in the The BMJ  involving more than 7,000 patients who had been hospitalized […] Continue reading ->
  Nearly 100 World Trade Organization member countries and entities could potentially swing behind a proposal by India and South Africa to enact a wide-ranging waiver of complex World Trade Organization requirements on the use of patented products, trade secrets and copyrights on health products during the pandemic, asserted the Médecins Sans Frontières (MSF) Access […] Continue reading ->
The U.S. Food and Drug Administration has issued an emergency use authorization (EUA) for the first COVID-19 diagnostic test for self-testing at home and that provides rapid results. The Lucira COVID-19 All-In-One Test Kit is a molecular-based single use test that is intended to detect the novel coronavirus SARS-CoV-2 that causes COVID-19. “While COVID-19 diagnostic […] Continue reading ->
Many Geneva-based health agencies have worked together for years to improve global access to diagnostics and treatment, but the COVID-19 pandemic has necessitated much closer collaboration and speedier decision-making. This is according to experts from the WHO co-sponsored  “ACT Accelerator” medicine access partnership – including UNITAID, the Foundation for Innovative New Diagnostics (FIND), and the […] Continue reading ->
The World Health Organization is encouraged by early results of the efficacy of the Moderna COVID-19 vaccine but its most immediate concern is the impact of the surge in cases in Europe and the Americas, threatening both health workers and health systems. “While we continue to receive encouraging news about COVID-19 vaccines and remain cautiously […] Continue reading ->
BREAKING – World Health Organization Director-General, Dr Tedros Adhanom Ghebreyesus has proposed the creation of a Swiss-based global repository for sharing pathogen materials and clinical samples related to potential outbreak threats – allowing for the more rapid development of medical interventions.  The COVID-19 pandemic has shown the urgent need for this kind of system, said […] Continue reading ->